John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
PUT
Dominion Energy
D
$58.6B
| $2.62M | 0.01% |
+37,000
| New | +$2.74M |
|
|
GHL
1027
DELISTED
Greenhill & Co., Inc.
GHL
| $2.62M | 0.01% |
66,133
-78,936
| -54% | -$3.09M |
|
1028
AngioDynamics
ANGO
$652M
| $2.62M | 0.01% |
147,356
-18,150
| -11% | -$337K |
|
1029
Supernus Pharmaceuticals
SUPN
$2.62B
| $2.61M | 0.01% |
216,110
+137,033
| +173% | +$1.29M |
|
|
KRFT
1030
PUT
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $2.61M | 0.01% |
+30,000
| New | +$1.98M |
|
|
SAFM
1031
DELISTED
Sanderson Farms Inc
SAFM
| $2.61M | 0.01% |
32,792
-23,266
| -42% | -$1.89M |
|
|
KAMN
1032
DELISTED
Kaman Corp
KAMN
| $2.6M | 0.01% |
61,262
+26,505
| +76% | +$1.06M |
|
1033
Customers Bancorp
CUBI
$2.67B
| $2.59M | 0.01% |
106,420
+95,513
| +876% | +$2.06M |
|
1034
CALL
DuPont de Nemours
DD
$18.5B
| $2.59M | 0.01% |
+21,324
| New | +$2.53M |
|
|
FCRD
1035
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $2.59M | 0.01% |
210,831
+2,061
| +1% | +$24.1K |
|
1036
Caleres
CAL
$459M
| $2.58M | 0.01% |
78,807
-109,723
| -58% | -$3.35M |
|
1037
Vera Bradley
VRA
$90.1M
| $2.58M | 0.01% |
158,945
+138,755
| +687% | +$2.56M |
|
1038
HUB Group
HUBG
$2.46B
| $2.58M | 0.01% |
+131,254
| New | +$2.47M |
|
|
KTWO
1039
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.58M | 0.01% |
+116,762
| New | +$2.39M |
|
1040
PUT
Air Products & Chemicals
APD
$68.2B
| $2.57M | 0.01% |
+18,377
| New | +$2.54M |
|
|
SBNY
1041
DELISTED
Signature Bank
SBNY
| $2.57M | 0.01% |
19,833
-134,287
| -87% | -$16.7M |
|
1042
Tilly's
TLYS
$114M
| $2.56M | 0.01% |
163,765
+33,453
| +26% | +$446K |
|
|
BKCC
1043
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $2.56M | 0.01% |
282,716
-244,146
| -46% | -$2.11M |
|
1044
PUT
Canadian Pacific Kansas City
CP
$83.2B
| $2.56M | 0.01% |
+70,000
| New | +$2.58M |
|
|
AV
1045
DELISTED
Aviva Plc
AV
| $2.55M | 0.01% |
157,932
-30,448
| -16% | -$494K |
|
1046
QuidelOrtho
QDEL
$994M
| $2.55M | 0.01% |
94,600
+44,983
| +91% | +$1.15M |
|
1047
Stepan Co
SCL
$1.41B
| $2.55M | 0.01% |
61,223
+3,525
| +6% | +$140K |
|
1048
Eldorado Gold
EGO
$12.1B
| $2.54M | 0.01% |
110,820
+102,480
| +1,229% | +$2.81M |
|
1049
Banco Santander
SAN
$214B
| $2.53M | 0.01% |
+358,398
| New | +$2.42M |
|
|
AHT
1050
Ashford Hospitality Trust
AHT
$21.5M
| $2.53M | 0.01% |
266
-19
| -7% | -$194K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.